Biểu đồ giá cổ phiếu ADMA
ADMA Giá
ADMA Biologics Inc
$8.41
6.72%
$0.53
Khi đóng cửa: May 12, 16:00:00 GMT-4
$8.62
2.49%
$0.2
Phiên sau giờ: May 12, 20:27:12 GMT-4
Quay lại
ADMA Biologics Inc (ADMA) Giá
Thống kê chính
Giá đóng cửa trước
$7.88
Giá mở cửa
$7.99
Phạm vi ngày
$7.97 - $8.62
Phạm vi 52 tuần
$7.21 - $25.67
Khối lượng
8.1M
Khối lượng trung bình
4.5M
Tỷ suất cổ tức
--
EPS (TTM)
0.60
Vốn hóa thị trường
$2.0B
ADMA là gì?
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The company is headquartered in Ramsey, New Jersey and currently employs 647 full-time employees. The company went IPO on 2013-10-17. The firm manufactures and markets three United States Food and Drug Administration (FDA)-approved plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases: ASCENIV (immune globulin intravenous, human-slra 10% liquid) for the treatment of primary humoral immunodeficiency (PI); BIVIGAM (immune globulin intravenous, human) for the treatment of PI; and NABI-HB (hepatitis B immune globulin, human) to provide enhanced immunity against the hepatitis B virus. Through its ADMA BioCenters subsidiary, the Company also operates as an FDA-approved source plasma collector in the United States, which provides its blood plasma for the manufacture of its products.
